The Valley Desk

LetterAmerican journal of hematologyPublished

The impact of post-remission granulocyte colony-stimulating factor use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed acute myeloid leukemia

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Letter
Venue
American journal of hematology
Published
PubMed ID
39487568
PubMed Central ID
PMC11625987
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal